US Patent Application No: 2009/0022,718

Number of patents in Portfolio can not be more than 2000

Methods of treating a blood pathology using anti-TNF antibodies and fragments thereof

Stats

ALSO PUBLISHED AS: 7744885
ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
CENTOCOR, INC.MALVERN, PA147
NEW YORK UNIVERSITYNEW YORK, NY806

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Daddona, Peter Menlo Park, CA 61 795
Ghrayeb, John Thorndale, PA 67 1183
Knight, David Berwyn, PA 115 1205
Le, Junming Jackson Heights, NY 56 1124
Siegel, Scott Westborough, MA 44 748
Vilcek, Jan New York, NY 55 1083

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
SCIATICON AB (5)
7,708,995 Use of TNF-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus 0 2006
7,906,481 Specific TNF-A inhibitors for treating spinal disorders mediated by nucleous pulposus 0 2007
7,811,990 Soluble cytokine receptors TNF-α blocking antibodies for treating spinal disorders mediated by nucleus pulposus 0 2007
7,723,357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus 0 2008
8,057,792 Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus 0 2010